U.S. Preventive Services Task Force: Prostate Cancer Final Recommendation Statement

U.S. Preventive Services Task Force: Prostate Cancer Final Recommendation Statement

Prostate Cancer: Screening & Genomics

CDC information: Prostate cancer screening - A prostate specific antigen (PSA) test may find a prostate health problem, but treatment can cause serious side effects. Learn about prostate cancer and talk to your doctor before you decide to get tested or treated for prostate cancer

The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer

Talking to men about PSA testing,  by Barak Gaster, New York Times, Aug 19  

CDC information: Risk factors for prostate cancer include genetics and family history

NCI information: Genetics of prostate cancer (PDQ)

Technology assessment report: Gene expression analysis for prostate cancer management,Blue Cross Blue Shield Health Technology Assessment Report, May 2014

Incorporating genomics into breast and prostate cancer screening: assessing the implications. 
Susmita Chowdhury MD, MPhil et al. Genetics in Medicine, 2013

CDC blog post: How can we use genetic testing in population screening for common diseases? Scientific and implementation challenges, (2013)